地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172431432
传真:15172469628
邮箱:sales@amyjet.com

艾美捷科技代理深圳鼎升(AcroGenic)全系列产品。
深圳鼎升生物科技有限公司成立于2022年7月29日,坐落在深圳光明区。公司专注于新一代合成生物材料研发及其在新兴生物医药领域中的应用,依托拥有中美自主专利的新型3D可调控高分
子合成生物材料 AccuraMatrix ®技术,实现产品化及市场化。
AcroGenic主营业务基于细胞三维培养和体内外模型平台建立及试剂耗材的生产,治疗性细胞的体外规模化生产及体内植入技术研究及市场化,合成生物平台的建立及合成产品的生产销售。
目前公司已设立北京、深圳和美国的研发及生产中心。
产品范围包括:
(1)AccuraMatrix®细胞外基质

人工合成的有机共聚大分子生物3D架构,能有效模拟细胞生长所需的稳定微环境。
拥有中美自主专利技术,可对架构的孔径大小、结构刚性等理化指标进行调节。
AccuraMatrix可根据培养细胞、细胞球、类器官及组织颗粒的培养需要,通过各类生物材料的不断开发和优化以达到在体外最大限度地模仿体内微环境从而实现多种人类干细胞及原代细胞的体外三维高密度大规模培养、扩增及体内外模型建立。AccuraMatrix细胞外基质产品有普适性强,生物安全性高,可植入性,低成本,高重复性和稳定批次质量。可用于干细胞生产,骨和软骨修复,人造腺体,细胞体内植入。
<<
(2)CTC体外培养试剂盒

肺癌循环肿瘤细胞培养试剂盒
肝癌循环肿瘤细胞培养试剂盒
肾癌循环肿瘤细胞培养试剂盒
胆管癌循环肿瘤细胞培养试剂盒
胰腺癌循环肿瘤细胞培养试剂盒
卵巢癌循环肿瘤细胞培养试剂盒
在AccuraMatrix系统可从外周血中体外培养、增殖,获得足够的数量的CTC,进行全面的分子与功能研究,如对肿瘤细胞与正常细胞物理特性差异的研究;对原发性肿瘤、CTC和转移灶进行基因表达谱的比较;对CTC不同表面标志物表达的研究;对CTC进行药物敏感度实验和建立动物转移模型等。有利于肿瘤患者早期诊断、辅助临床进行精确治疗、术后肿瘤复发与转移及预后评估等。

应用场景

AccuraMatrixCTC培养可用于肿瘤无创早诊、复发监测、用药指导。细胞外生物材料技术涵盖肿瘤早、中、晚全阶段,早期高危和高度怀疑患者的诊断(液体活检,基因诊断无法确诊),
CTC可以通过对肿瘤细胞的病历诊断做到无创确诊;支持低成本长期培养,可以帮助患者建立起抗药肿瘤模型,并提前筛选出药效药物,指导肿瘤复发治疗,利用CTC培养对治疗效果进
行评估,监测肿瘤复发;晚期病人获得肿瘤样品难, 通过CTC为病人寻找有效药物和药物组合。
另外,AccuraMatrix体外培养扩增后的CTC细胞团可用于动物模型构建,支持肿瘤新药研发、监测肿瘤复发、疗效评估和用药指导。
循环肿瘤细胞体外培养 的基质材料优化及其相关临床应用产品的研发,实现了高成功率循环肿瘤细胞体外培养,建立了世界唯一的循环肿瘤细胞动物体内种植方法,成功地利用循环肿
瘤细胞动物模型进行了体内抗癌药物评估。
目前,AccuraMatrix已完成部分癌种CTC扩增培养和蛋白鉴定。
(3)类器官培养试剂盒

依托生物基质材料在体外最大限度地模拟体内微环境,实现多种类器官快速构建,并支持类器官与免疫细胞长时间共培养。为抗癌新药研发和患者治疗方案的筛选提供高效、准确、高性价比的服务,为癌症基础研究提供不可或缺的体外 3D 肿瘤模型及动物模型。
<肺癌类器官培养试剂盒
肝癌类器官培养试剂盒
肾癌类器官培养试剂盒
胆管癌类器官培养试剂盒
胰腺癌类器官培养试剂盒
结直肠癌类器官培养试剂盒
尿道上皮癌类器官培养试剂盒
胃癌类器官培养试剂盒
卵巢癌类器官培养试剂盒
乳腺癌类器官培养试剂盒
恶性体腔积液类器官培养试剂盒
肝癌组织类器官培养试剂盒


(4)利用3D培养技术体外生产治疗性蛋白
针对生物合成中存在的某些问题,通过在细胞培养中应用不同的生物材料实现了对细胞培养微环境的调控,改变了细胞状态,实现了多种细胞的共同培养,更换表达细胞种类,从而解决了一定的技术瓶颈



EZ BioResearch位于美国马萨诸塞州St. Louis,是一家专门从事研发、生产、销售高品质实验室消耗品的公司。公司使命是1)通过创新,研制出易用的分子生物学试剂;2)让产品具有高性价比。
EZ BioResearch is an innovation-driven biotech company which focuses on developing, manufacturing and distributing advanced molecular biology tool kits and high quality laboratory consumable products. We subscribe to the notion that innovation is the most important key to advance science and technology. We have developed a series of novel easy-to-use molecular biology kits. Some of these new products (Fast PCR Genotyping Kits, High Speed Plasmid Maxiprep Kit and Quantitative DNA Even Ladders) have unique features and superior quality which are unmatched by any similar products on the market.
产品主要包括:
Tissue/Tail PCR Genotyping
SV Tissue/Tail Genotyping
Eco-Direct Tissue/Tail Genotyping
Blood/Cell PCR Genotyping
Zebrafish PCR Genotyping
Tissue/Tail DNA + PCR Kit
High MW Tail DNA + PCR Kit
Taq DNA Polymerase
Turbo Taq DNA Polymerase
HotStart Taq DNA Polymerase
HF Taq DNA Polymerase
Long Taq DNA Polymerase
2X Taq Master Mix
2X Taq Red Master Mix
2X Turbo Taq Master Mix
2X Turbo Taq Red Master Mix
dNTP Mix
Tissue/Tail DNA Isolation
Blood/Cells DNA Isolation
High MW Tissue DNA Isolation
High MW Blood DNA Isolation
High MW Tail DNA Isolation
High MW Cell DNA Isolation
High MW Bacterial DNA Isolation
Plasmid Miniprep
High Speed Plasmid Maxiprep
Plasmid Maxiprep
PCR Clean-Up
Gel Extraction
Tissue/cell RNA Mini Kit
Tissue/cell RNA Mini Plus Kit
RNA Clean-Up
RNA Clean-Up Plus DNase Kit
EZ Blood Total RNA Isolation
Stabilized Blood RNA Isolation
EZ RNA Storage Solution
EZ MicroElute-10 DNA Clean-Up Kit
EZ MicroElute-25 DNA Clean-Up Kit
EZ DNA MW Markers
EZ Protein MW Markers
Water and Reagents
Agar Plates for Bacterial Growth
Pipette Tips
PCR Tubes
Microcentrifuge Tubes
Centrifuge Tubes
Culture Tubes
T-shape Spreaders
Inoculating Needles
Petri Dishes
Freezer Boxes
Plastic Freezer Boxes
Cryogenic Vials
Cell Culture Plates
Cell Culture Flasks
Cell Culture Chamber Slides
Cell Culture Dishes
Cell Scrapers and Lifters
Serological Pipettes
Cell Strainer
Science Kits
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="EZ BioResearch"> EZ BioResearch
艾美捷科技有限公司代理Affinity Biologicals公司产品,如下:
(1)Matched-Pair Antibody Sets
http://www.amyjet.com/Index/lists/catid/27/kid/52/p/1.html
(2)Factor Inhibitor Plasmas
http://www.amyjet.com/Index/lists/catid/27/kid/52/p/2.html
(3)Control Plasma-Diagnostic
http://www.amyjet.com/Index/lists/catid/27/kid/52/p/2.html
(4)Deficient Plasmas
http://www.amyjet.com/Index/lists/catid/27/kid/52/p/3.html
(5)Complete ELISA Kit
http://www.amyjet.com/Index/lists/catid/27/kid/52/p/5.html
(6)Antibodies
http://www.amyjet.com/Index/lists/catid/27/kid/52/p/6.html
Affinity Biologicals公司成立于1987年,提供包括凝血相关抗体、ELISA试剂盒、无蛋白酶抑制剂血浆和校准血浆等系列产品。Affinity Biologicals还提供蛋白纯化、抗体生产、检测方法开发、定制生产等服务。
Affinity Biologicals, Inc. is a primary manufacturer of products used worldwide in thrombosis and hemostasis research and medical diagnostics. Our products include an extensive line of antibodies to coagulation and hemostasis related proteins, conjugates, antibody pairs for immunoassay of human and animal analytes, the VisuLize line of complete ELISA kits, and a full line of human plasma products including immune-depleted plasmas, calibrators and controls. Custom Services include protein purification, antibody production, assay development, custom manufacturing and lyophilization.
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Affinity Biologicals"> Affinity Biologicals艾美捷科技授权代理Bioclone品牌全系列产品。
【快速入口】
丁香通:https://vicbio.biomart.cn/supply/c_cate-582257.htm
艾美捷科技商城:http://www.amyjet.com/Index/lists/catid/27/kid/74.html
【品牌介绍】

美国Bioclone Inc.公司成立已逾20年,其独特的“一步法”生物磁分离技术,已经在全球生物科学研究领域得到广泛应用,无论是大规模批量生产还是微量的生物样品处理,该技术都具有快速、简单、操作灵活的优势,目前是磁珠行业内先进技术的领跑者。我司代理Bioclone产品范围包括:负向磁珠、法医类试剂盒、蛋白纯化试剂、荧光磁珠、免疫磁珠、离子交换磁珠、反相磁珠及其他试剂盒等。
【一步法纯化平台】

【产品列表】
| 货号 | 中文名称 | 规格 | 价格(人民币) |
| FA101 | 1µm BcMag™ 氨基磁珠 150mg | 150mg | 4125 |
| FA102 | 1µm BcMag™ 氨基磁珠 300mg | 300mg | 7875 |
| FA103 | 5µm BcMag™ 氨基磁珠 150mg | 150mg | 4125 |
| FA104 | 5µm BcMag™ 氨基磁珠 300mg | 300mg | 7875 |
| FA105 | 1µm BcMag™ DADPA活化磁珠 150mg | 150mg | 4875 |
| FA106 | 2µm BcMag™ DADPA活化磁珠 300mg | 300mg | 9150 |
| FA107 | 5µm BcMag™ DADPA活化磁珠 150mg | 150mg | 4875 |
| FA108 | 5µm BcMag™ DADPA活化磁珠 300mg | 300mg | 9150 |
| FA113 | 1µm BcMag™ 长链氨基磁珠 150mg | 150mg | 4875 |
| FA114 | 1µm BcMag™ 长链氨基磁珠 300mg | 300mg | 9150 |
| FA115 | 5µm BcMag™ 长链氨基磁珠 150mg | 150mg | 4875 |
| FA116 | 5µm BcMag™ 长链氨基磁珠 300mg | 300mg | 9150 |
| FB101 | 1µm BcMag™ 羧基磁珠 150mg | 150mg | 4125 |
| FB102 | 1µm BcMag™ 羧基磁珠 300mg | 300mg | 7875 |
| FB103 | 5µm BcMag™ 羧基磁珠 150mg | 150mg | 4125 |
| FB104 | 5µm BcMag™ 羧基磁珠 300mg | 300mg | 7875 |
| FB105 | 1µm BcMag™ 长链羧基磁珠 150mg | 150mg | 4875 |
| FB106 | 1µm BcMag™ 长链羧基磁珠 300mg | 300mg | 9150 |
| FB107 | 5µm BcMag™ 长链羧基磁珠 150mg | 150mg | 4875 |
| FB108 | 5µm BcMag™ 长链羧基磁珠 300mg | 300mg | 9150 |
| FB113 | BcMag™ 羧基磁珠偶连试剂盒 | Kit | 4125 |
| FC101 | 1µm BcMag™ 环氧基活化磁珠 150mg | 150mg | 4125 |
| FC102 | 1µm BcMag™ 环氧基活化磁珠 300mg | 300mg | 7875 |
| FC103 | 5µm BcMag™ 环氧基活化磁珠 150mg | 150mg | 4125 |
| FC104 | 5µm BcMag™ 环氧基活化磁珠 300mg | 300mg | 7875 |
| FC105 | 1µm BcMag™ 长链环氧基活化磁珠 150mg | 150mg | 4875 |
| FC106 | 1µm BcMag™ 长链环氧基活化磁珠 300mg | 300mg | 9150 |
| FC107 | 5µm BcMag™ 长链环氧基活化磁珠 150mg | 150mg | 4875 |
| FC108 | 5µm BcMag™ 长链环氧基活化磁珠 300mg | 300mg | 9150 |
| FC109 | BcMag™ 环氧基活化磁珠偶连试剂盒 | Kit | 4125 |
| FD101 | 1µm BcMag™ 酰肼基磁珠 150mg | 150mg | 4125 |
| FD102 | 1µm BcMag™ 酰肼基磁珠 300mg | 300mg | 7875 |
| FD103 | 5µm BcMag™ 酰肼基磁珠 150mg | 150mg | 4125 |
| FD104 | 5µm BcMag™ 酰肼基磁珠 300mg | 300mg | 7875 |
| FD105 | BcMag™ 酰肼基磁珠偶连试剂盒 | Kit | 4125 |
| FD106 | BcMag™ 糖蛋白和抗体结合试剂盒,含1um酰肼磁珠 kit | kit | 5250 |
| FD107 | BcMag™ 糖蛋白和抗体结合试剂盒,含1um可洗脱式酰肼磁珠 kit | kit | 6750 |
| FE101 | 1µm BcMag™ 醛基磁珠 150mg | 150mg | 4125 |
| FE102 | 1µm BcMag™ 醛基磁珠 300mg | 300mg | 7875 |
| FE103 | 5µm BcMag™ 醛基磁珠 150mg | 150mg | 4125 |
| FE104 | 5µm BcMag™ 醛基磁珠 300mg | 300mg | 7875 |
| FE105 | 1µm BcMag™ 长链醛基磁珠 150mg | 150mg | 4875 |
| FE106 | 1µm BcMag™ 长链醛基磁珠 300mg | 300mg | 9150 |
| FE107 | 5µm BcMag™ 长链醛基磁珠 150mg | 150mg | 4875 |
| FE108 | 5µm BcMag™ 长链醛基磁珠 300mg | 300mg | 9150 |
| FE109 | BcMag™ 醛基磁珠偶连试剂盒 | Kit | 4125 |
| FF101 | 1µm BcMag™ 二氧化硅改良磁珠磁珠 150mg | 150mg | 3750 |
| FF102 | 1µm BcMag™ 二氧化硅改良磁珠磁珠 300mg | 300mg | 6750 |
| FF103 | 5µm BcMag™ 二氧化硅改良磁珠磁珠 150mg | 150mg | 3750 |
| FF104 | 5µm BcMag™ 二氧化硅改良磁珠磁珠 300mg | 300mg | 6750 |
| FF105 | 1µm BcMag™ IDA磁珠 5ml | 5ml | 4125 |
| FF106 | 1µm BcMag™ IDA磁珠 10ml | 10ml | 7875 |
| FF109 | 5µm BcMag™ IDA磁珠 150mg | 150mg | 4125 |
| FF110 | 5µm BcMag™ IDA磁珠 300mg | 300mg | 7875 |
| FG101 | 1µm BcMag™ 碘乙酰基活性磁珠 150mg | 150mg | 4125 |
| FG102 | 1µm BcMag™ 碘乙酰基活性磁珠 300mg | 300mg | 7875 |
| FG103 | 5µm BcMag™ 碘乙酰基活性磁珠 150mg | 150mg | 4125 |
| FG104 | 5µm BcMag™ 碘乙酰基活性磁珠 300mg | 300mg | 7875 |
| FG105 | 1µm BcMag™ 长链碘乙酰基活性磁珠 150mg | 150mg | 4875 |
| FG106 | 1µm BcMag™ 长链碘乙酰基活性磁珠 300mg | 300mg | 9150 |
| FG107 | 5µm BcMag™ 长链碘乙酰基活性磁珠 150mg | 150mg | 4875 |
| FG108 | 5µm BcMag™ 长链碘乙酰基活性磁珠 300mg | 300mg | 9150 |
| FG109 | BcMag™ 多肽偶联试剂盒,含1um碘乙酰基磁珠 Kit | Kit | 5250 |
| FG110 | BcMag™ 多肽偶联试剂盒,含1um可洗脱式碘乙酰基磁珠 Kit | Kit | 6750 |
| FG113 | BcMag™ 碘乙酰基磁珠偶连试剂盒 | Kit | 4125 |
| FH101 | 1µm BcMag™ DVS磁珠 150mg | 150mg | 4125 |
| FH102 | 1µm BcMag™ DVS磁珠 300mg | 300mg | 7875 |
| FH103 | 5µm BcMag™ DVS磁珠 150mg | 150mg | 4125 |
| FH104 | 5µm BcMag™ DVS磁珠 300mg | 300mg | 7875 |
| FI101 | 1µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4125 |
| FI102 | 1µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 7875 |
| FI103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4125 |
| FI104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 7875 |
| FI105 | 1µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4875 |
| FI106 | 1µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9150 |
| FI107 | 5µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4875 |
| FI108 | 5µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9150 |
| FI109 | BcMag™ NHS磁珠偶连试剂盒 | Kit | 4125 |
| FJ101 | 1µm BcMag™ 羟基磁珠 150mg | 150mg | 4125 |
| FJ102 | 1µm BcMag™ 羟基磁珠 300mg | 300mg | 7875 |
| FJ103 | 5µm BcMag™ 羟基磁珠 150mg | 150mg | 4125 |
| FJ104 | 5µm BcMag™ 羟基磁珠 300mg | 300mg | 7875 |
| FJ105 | 1µm BcMag™ 长链羟基磁珠 150mg | 150mg | 4875 |
| FJ106 | 1µm BcMag™ 长链羟基磁珠 300mg | 300mg | 9150 |
| FJ107 | 5µm BcMag™ 长链羟基磁珠 150mg | 150mg | 4875 |
| FJ108 | 5µm BcMag™ 长链羟基磁珠 300mg | 300mg | 9150 |
| FP101 | 1µm BcMag™ 巯基磁珠 150mg | 150mg | 4125 |
| FP102 | 1µm BcMag™ 巯基磁珠 300mg | 300mg | 7875 |
| FP103 | 5µm BcMag™ 巯基磁珠 150mg | 150mg | 4125 |
| FP104 | 5µm BcMag™ 巯基磁珠 300mg | 300mg | 7875 |
| FP105 | 1µm BcMag™ 长链巯基磁珠 150mg | 150mg | 4875 |
| FP106 | 1µm BcMag™ 长链巯基磁珠 300mg | 300mg | 9150 |
| FP107 | 5µm BcMag™ 长链巯基磁珠 150mg | 150mg | 4875 |
| FP108 | 5µm BcMag™ 长链巯基磁珠 300mg | 300mg | 9150 |
| FR101 | 1µm BcMag™ 对甲苯磺酰基磁珠 150mg | 150mg | 4125 |
| FR102 | 1µm BcMag™ 对甲苯磺酰基磁珠 300mg | 300mg | 7875 |
| FR103 | 5µm BcMag™ 对甲苯磺酰基磁珠 150mg | 150mg | 4125 |
| FR104 | 5µm BcMag™ 对甲苯磺酰基磁珠 300mg | 300mg | 7875 |
| FR105 | 1µm BcMag™ 长链对甲苯磺酰基磁珠 150mg | 150mg | 4875 |
| FR106 | 1µm BcMag™ 长链对甲苯磺酰基磁珠 300mg | 300mg | 9150 |
| FR107 | 5µm BcMag™ 长链对甲苯磺酰基磁珠 150mg | 150mg | 4875 |
| FR108 | 5µm BcMag™ 长链对甲苯磺酰基磁珠 300mg | 300mg | 9150 |
| FW101 | 1µm BcMag™ CDI磁珠 150mg | 150mg | 4125 |
| FW102 | 1µm BcMag™ CDI磁珠 300mg | 300mg | 7875 |
| FW103 | 5µm BcMag™ CDI磁珠 150mg | 150mg | 4125 |
| FW104 | 5µm BcMag™ CDI磁珠 300mg | 300mg | 7875 |
| FW111 | BcMag™ CDI磁珠偶连试剂盒 | Kit | 4125 |
| FX101 | 1µm BcMag™ 硫醇基磁珠 150mg | 150mg | 4125 |
| FX102 | 1µm BcMag™ 硫醇基磁珠 300mg | 300mg | 7875 |
| FX103 | 5µm BcMag™ 硫醇基磁珠 150mg | 150mg | 4125 |
| FX104 | 5µm BcMag™ 硫醇基磁珠 300mg | 300mg | 7875 |
| FX105 | 1µm BcMag™ 长链硫醇基磁珠 150mg | 150mg | 4875 |
| FX106 | 1µm BcMag™ 长链硫醇基磁珠 300mg | 300mg | 9150 |
| FX107 | 5µm BcMag™ 长链硫醇基磁珠 150mg | 150mg | 4875 |
| FX108 | 5µm BcMag™ 长链硫醇基磁珠 300mg | 300mg | 9150 |
| IL101 | 1µm BcMag™ 炔基磁珠 150mg | 150mg | 4125 |
| IL102 | 1µm BcMag™ 炔基磁珠 300mg | 300mg | 7875 |
| IL103 | 5µm BcMag™ 炔基磁珠 150mg | 150mg | 4125 |
| IL104 | 5µm BcMag™ 炔基磁珠 300mg | 300mg | 7875 |
| IM101 | 1µm BcMag™ 叠氮基活化磁珠 150mg | 150mg | 4125 |
| IM102 | 1µm BcMag™ 叠氮基活化磁珠 300mg | 300mg | 7875 |
| IM103 | 5µm BcMag™ 叠氮基活化磁珠 150mg | 150mg | 4125 |
| IM104 | 5µm BcMag™ 叠氮基活化磁珠 300mg | 300mg | 7875 |
| IA101 | 1µm BcMag™ 可洗脱式氨基磁珠 150mg | 150mg | 5625 |
| IA102 | 1µm BcMag™ 可洗脱式氨基磁珠 300mg | 300mg | 9750 |
| IA103 | 2.5µm BcMag™ 可洗脱式氨基磁珠 150mg | 150mg | 5625 |
| IA104 | 2.5µm BcMag™ 可洗脱式氨基磁珠 300mg | 300mg | 9750 |
| IB101 | 1µm BcMag™ 可洗脱式羧基磁珠 150mg | 150mg | 5625 |
| IB102 | 1µm BcMag™ 可洗脱式羧基磁珠 300mg | 300mg | 9750 |
| IB103 | 2.5µm BcMag™ 可洗脱式羧基磁珠 150mg | 150mg | 5625 |
| IB104 | 2.5µm BcMag™ 可洗脱式羧基磁珠 300mg | 300mg | 9750 |
| IC101 | 1µm BcMag™ 可洗脱式环氧基活化磁珠 150mg | 150mg | 5625 |
| IC102 | 1µm BcMag™ 可洗脱式环氧基活化磁珠 300mg | 300mg | 9750 |
| IC103 | 2.5µm BcMag™ 可洗脱式环氧基活化磁珠 150mg | 150mg | 5625 |
| IC104 | 2.5µm BcMag™ 可洗脱式环氧基活化磁珠 300mg | 300mg | 9750 |
| ID101 | 1µm BcMag™ 可洗脱式酰肼基磁珠 150mg | 150mg | 5625 |
| ID102 | 1µm BcMag™ 可洗脱式酰肼基磁珠 300mg | 300mg | 9750 |
| ID103 | 2.5µm BcMag™ 可洗脱式酰肼基磁珠 150mg | 150mg | 5625 |
| ID104 | 2.5µm BcMag™ 可洗脱式酰肼基磁珠 300mg | 300mg | 9750 |
| IE101 | 1µm BcMag™ 可洗脱式醛基磁珠 150mg | 150mg | 5625 |
| IE102 | 1µm BcMag™ 可洗脱式醛基磁珠 300mg | 300mg | 9750 |
| IE103 | 2.5µm BcMag™ 可洗脱式醛基磁珠 150mg | 150mg | 5625 |
| IE104 | 2.5µm BcMag™ 可洗脱式醛基磁珠 300mg | 300mg | 9750 |
| IG101 | 1µm BcMag™ 可洗脱式碘乙酰基活性磁珠 150mg | 150mg | 5625 |
| IG102 | 1µm BcMag™ 可洗脱式碘乙酰基活性磁珠 300mg | 300mg | 9750 |
| IG103 | 2.5µm BcMag™ 可洗脱式碘乙酰基活性磁珠 150mg | 150mg | 5625 |
| IG104 | 2.5µm BcMag™ 可洗脱式碘乙酰基活性磁珠 300mg | 300mg | 9750 |
| II101 | 1µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 5625 |
| II102 | 1µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9750 |
| II103 | 2.5µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 5625 |
| II104 | 2.5µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9750 |
| IJ101 | 1µm BcMag™ 可洗脱式叠氮基活化磁珠 150mg | 150mg | 5625 |
| IJ102 | 1µm BcMag™ 可洗脱式叠氮基活化磁珠 300mg | 300mg | 9750 |
| IJ103 | 2.5µm BcMag™ 可洗脱式叠氮基活化磁珠 150mg | 150mg | 5625 |
| IJ104 | 2.5µm BcMag™ 可洗脱式叠氮基活化磁珠 300mg | 300mg | 9750 |
| IK101 | 1µm BcMag™ 可洗脱式 炔基磁珠 150mg | 150mg | 5625 |
| IK102 | 1µm BcMag™ 可洗脱式 炔基磁珠 300mg | 300mg | 9750 |
| IK103 | 2.5µm BcMag™ 可洗脱式 炔基磁珠 150mg | 150mg | 5625 |
| IK104 | 2.5µm BcMag™ 可洗脱式 炔基磁珠 300mg | 300mg | 9750 |
| IR101 | 1µm BcMag™ 可洗脱式 对甲苯磺酰基磁珠 150mg | 150mg | 5625 |
| IR102 | 1µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 300mg | 300mg | 9750 |
| IR103 | 2.5µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 150mg | 150mg | 5625 |
| IR104 | 2.5µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 300mg | 300mg | 9750 |
| AA101 | BcMag™ 一步法哺乳动物细胞DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AA102 | BcMag™ 一步法哺乳动物细胞DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AE101 | BcMag™ 一步法细菌DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AE102 | BcMag™ 一步法细菌DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AF101 | BcMag™ 一步法血液DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AF102 | BcMag™ 一步法血液DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AG101 | BcMag™ 一步法口腔细胞DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AG102 | BcMag™ 一步法口腔细胞DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AH101 | BcMag™ 一步法DNA/RNA纯化试剂盒 1ml | 1ml | 2250 |
| AH102 | BcMag™ 一步法DNA/RNA纯化试剂盒 5ml | 5ml | 6750 |
| AI101 | BcMag™ 一步法一代测序纯化试剂盒 1ml | 1ml | 2250 |
| AI102 | BcMag™ 一步法一代测序纯化试剂盒 5ml | 5ml | 6750 |
| AJ101 | BcMag™ One-Step FFPE & FNA DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AJ102 | BcMag™ One-Step FFPE & FNA DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AK101 | BcMag™ 一步法荧光标记物清除试剂盒 1ml | 1ml | 2250 |
| AK102 | BcMag™ 一步法荧光标记物清除试剂盒 5ml | 5ml | 10350 |
| AL101 | BcMag™ 一步法真菌和酵母DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AL102 | BcMag™ 一步法真菌和酵母DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AM101 | BcMag™ 一步法昆虫DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AM102 | BcMag™ 一步法昆虫DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AN101 | BcMag™ 一步法鼠尾DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AN102 | BcMag™ 一步法鼠尾DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AO101 | BcMag™ 一步法NGS纯化试剂盒 1ml | 1ml | 2250 |
| AO102 | BcMag™ 一步法NGS纯化试剂盒 5ml | 5ml | 10350 |
| AP101 | BcMag™ 一步法PCR纯化试剂盒 1ml | 1ml | 2250 |
| AP102 | BcMag™ 一步法PCR纯化试剂盒 5ml | 5ml | 10350 |
| AQ101 | BcMag™ 一步法植物DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AQ102 | BcMag™ 一步法植物DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AR101 | BcMag™ 一步法唾液病毒RNA-DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AR102 | BcMag™ 一步法唾液病毒RNA-DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AU101 | BcMag™ 一步法RNA清除试剂盒 1ml | 1ml | 2250 |
| AU102 | BcMag™ 一步法RNA清除试剂盒 3ml | 3ml | 5250 |
| AV101 | BcMag™ 一步法DNA/RNA清除试剂盒 1ml | 1ml | 2250 |
| AV102 | BcMag™ 一步法DNA/RNA清除试剂盒 3ml | 3ml | 5250 |
| AW101 | BcMag™ 一步法单链DNA清除试剂盒 1ml | 1ml | 2250 |
| AW102 | BcMag™ 一步法单链DNA清除试剂盒 3ml | 3ml | 5250 |
| AB101 | BcMag™ 骨骼DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AB102 | BcMag™ 骨骼DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AC101 | BcMag™ 游离DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AC102 | BcMag™ 游离DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AD101 | BcMag™ 发干DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AD102 | BcMag™ 发干DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AF101 | BcMag™ 一步法血液DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AF102 | BcMag™ 一步法血液DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AS101 | BcMag™ 一步法脱落细胞DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AS102 | BcMag™ 一步法脱落细胞DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AT101 | BcMag™ 精斑DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AT102 | BcMag™ 精斑DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AX101 | BcMag™ 一步法PCR抑制剂清除试剂盒 1ml | 1ml | 2250 |
| AX102 | BcMag™ 一步法PCR抑制剂清除试剂盒 5ml | 5ml | 10350 |
| AZ101 | BcMag™ 一步法指纹DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AZ102 | BcMag™ 一步法指纹DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AAA101 | BcMag™ 一步法头皮屑DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AAA102 | BcMag™ 一步法头皮屑DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| MG101 | BcMag™ GST-标签蛋白纯化试剂盒 Kit | Kit | 4425 |
| MG102 | BcMag™ GST-标签蛋白纯化试剂盒 5ml | 5ml | 5925 |
| MG103 | BcMag™ GST-标签蛋白纯化试剂盒 10ml | 10ml | 8250 |
| MHN101 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHN102 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHN103 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 50ml | 50ml | 37500 |
| MHO101 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHO102 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHO103 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 50ml | 50ml | 37500 |
| MHP101 | BcMag™ 分泌型His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHP102 | BcMag™ 分泌型His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHQ101 | BcMag™ 低表达量His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHQ102 | BcMag™ 低表达量His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| HA101 | 2.5µm BcMag™ 链霉亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HA102 | 2.5µm BcMag™ 链霉亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HA103 | 5µm BcMag™ 链霉亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HA104 | 5µm BcMag™ 链霉亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HB101 | 2.5µm BcMag™ 链霉亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HB102 | 2.5µm BcMag™ 链霉亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HB103 | 5µm BcMag™ 链霉亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HB104 | 5µm BcMag™ 链霉亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HC101 | 2.5µm BcMag™ 链霉亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HC102 | 2.5µm BcMag™ 链霉亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HC103 | 5µm BcMag™ 链霉亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HC104 | 5µm BcMag™ 链霉亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HD101 | 2.5µm BcMag™ 单体亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HD102 | 2.5µm BcMag™ 单体亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HD103 | 5µm BcMag™ 单体亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HD104 | 5µm BcMag™ 单体亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HE101 | 2.5µm BcMag™ 单体亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HE102 | 2.5µm BcMag™ 单体亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HE103 | 5µm BcMag™ 单体亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HE104 | 5µm BcMag™ 单体亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HF101 | 2.5µm BcMag™ 单体亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HF102 | 2.5µm BcMag™ 单体亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HF103 | 5µm BcMag™ 单体亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HF104 | 5µm BcMag™ 单体亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HG101 | 2.5µm BcMag™ 蛋白A/G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HG102 | 2.5µm BcMag™ 蛋白A/G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HG103 | 5µm BcMag™ 蛋白A/G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HG104 | 5µm BcMag™ 蛋白A/G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HH101 | 2.5µm BcMag™ 蛋白A/G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HH102 | 2.5µm BcMag™ 蛋白A/G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HH103 | 5µm BcMag™ 蛋白A/G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HH104 | 5µm BcMag™ 蛋白A/G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HI101 | 2.5µm BcMag™ 蛋白A/G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HI102 | 2.5µm BcMag™ 蛋白A/G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HI103 | 5µm BcMag™ 蛋白A/G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HI104 | 5µm BcMag™ 蛋白A/G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HJ101 | 2.5µm BcMag™ 蛋白A铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HJ102 | 2.5µm BcMag™ 蛋白A铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HJ103 | 5µm BcMag™ 蛋白A铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HJ104 | 5µm BcMag™ 蛋白A铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HK101 | 2.5µm BcMag™ 蛋白A铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HK102 | 2.5µm BcMag™ 蛋白A铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HK103 | 5µm BcMag™ 蛋白A铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HK104 | 5µm BcMag™ 蛋白A铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HL101 | 2.5µm BcMag™ 蛋白A钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HL102 | 2.5µm BcMag™ 蛋白A钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HL103 | 5µm BcMag™ 蛋白A钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HL104 | 5µm BcMag™ 蛋白A钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HM101 | 2.5µm BcMag™ 蛋白G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HM102 | 2.5µm BcMag™ 蛋白G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HM103 | 5µm BcMag™ 蛋白G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HM104 | 5µm BcMag™ 蛋白G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HN101 | 2.5µm BcMag™ 蛋白G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HN102 | 2.5µm BcMag™ 蛋白G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HN103 | 5µm BcMag™ 蛋白G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HN104 | 5µm BcMag™ 蛋白G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HO101 | 2.5µm BcMag™ 蛋白G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HO102 | 2.5µm BcMag™ 蛋白G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HO103 | 5µm BcMag™ 蛋白G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HO104 | 5µm BcMag™ 蛋白G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HP101 | 2.5µm BcMag™ 蛋白L铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HP102 | 2.5µm BcMag™ 蛋白L铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HP103 | 5µm BcMag™ 蛋白L铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HP104 | 5µm BcMag™ 蛋白L铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HQ101 | 2.5µm BcMag™ 蛋白L铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HQ102 | 2.5µm BcMag™ 蛋白L铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HQ103 | 5µm BcMag™ 蛋白 L铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HQ104 | 5µm BcMag™ 蛋白L铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HR101 | 2.5µm BcMag™ 蛋白L钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HR102 | 2.5µm BcMag™ 蛋白L钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HR103 | 5µm BcMag™ 蛋白L钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HR104 | 5µm BcMag™ 蛋白L钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| GA101 | 2.5µm BcMag™ 醛基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GA102 | 2.5µm BcMag™ 醛基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GA103 | 5µm BcMag™ 醛基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GA104 | 5µm BcMag™ 醛基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GB101 | 2.5µm BcMag™ 醛基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GB102 | 2.5µm BcMag™ 醛基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GB103 | 5µm BcMag™ 醛基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GB104 | 5µm BcMag™ 醛基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GC101 | 2.5µm BcMag™ 醛基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GC102 | 2.5µm BcMag™ 醛基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GC103 | 5µm BcMag™ 醛基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GC104 | 5µm BcMag™ 醛基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GD101 | 2.5µm BcMag™ 氨基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GD102 | 2.5µm BcMag™ 氨基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GD103 | 5µm BcMag™ 氨基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GD104 | 5µm BcMag™ 氨基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GE101 | 2.5µm BcMag™ 氨基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GE102 | 2.5µm BcMag™ 氨基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GE103 | 5µm BcMag™ 氨基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GE104 | 5µm BcMag™ 氨基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GF101 | 2.5µm BcMag™ 氨基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GF102 | 2.5µm BcMag™ 氨基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GF103 | 5µm BcMag™ 氨基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GF104 | 5µm BcMag™ 氨基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GG101 | 2.5µm BcMag™ 羧基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GG102 | 2.5µm BcMag™ 羧基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GG103 | 5µm BcMag™ 羧基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GG104 | 5µm BcMag™ 羧基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GH101 | 2.5µm BcMag™ 羧基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GH102 | 2.5µm BcMag™ 羧基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GH103 | 5µm BcMag™ 羧基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GH104 | 5µm BcMag™ 羧基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GI101 | 2.5µm BcMag™ 羧基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GI102 | 2.5µm BcMag™ 羧基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GI103 | 5µm BcMag™ 羧基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GI104 | 5µm BcMag™ 羧基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GJ101 | 2.5µm BcMag™ 酰肼基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GJ102 | 2.5µm BcMag™ 酰肼基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GJ103 | 5µm BcMag™ 酰肼基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GJ104 | 5µm BcMag™ 酰肼基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GK101 | 2.5µm BcMag™ 酰肼基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GK102 | 2.5µm BcMag™ 酰肼基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GK103 | 5µm BcMag™ 酰肼基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GK104 | 5µm BcMag™ 酰肼基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GL101 | 2.5µm BcMag™ 酰肼基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GL102 | 2.5µm BcMag™ 酰肼基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GL103 | 5µm BcMag™ 酰肼基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GL104 | 5µm BcMag™ 酰肼基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GM101 | 2.5µm BcMag™ 碘乙酰基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GM102 | 2.5µm BcMag™ 碘乙酰基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GM103 | 5µm BcMag™ 碘乙酰基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GM104 | 5µm BcMag™ 碘乙酰基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GN101 | 2.5µm BcMag™ 碘乙酰基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GN102 | 2.5µm BcMag™ 碘乙酰基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GN103 | 5µm BcMag™ 碘乙酰基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GN104 | 5µm BcMag™ 碘乙酰基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GO101 | 2.5µm BcMag™ 碘乙酰基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GO102 | 2.5µm BcMag™ 碘乙酰基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GO103 | 5µm BcMag™ 碘乙酰基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GO104 | 5µm BcMag™ 碘乙酰基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GP101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 15mg | 15mg | 3750 |
| GP102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 30mg | 30mg | 6750 |
| GP103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 15mg | 15mg | 3750 |
| GP104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 30mg | 30mg | 6750 |
| GQ101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 15mg | 15mg | 3750 |
| GQ102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 30mg | 30mg | 6750 |
| GQ103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 15mg | 15mg | 3750 |
| GQ104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 30mg | 30mg | 6750 |
| GR101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 15mg | 15mg | 3750 |
| GR102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 30mg | 30mg | 6750 |
| GR103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 15mg | 15mg | 3750 |
| GR104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 30mg | 30mg | 6750 |
| MA101 | BcMag™ 蛋白 A/G 纯化试剂盒 Kit | Kit | 5250 |
| MA102 | BcMag™ 蛋白 A/G 磁珠 5ml | 5ml | 5850 |
| MA103 | BcMag™ 蛋白 A/G 磁珠 10ml | 10ml | 9750 |
| MAA101 | BcMag™ 蛋白 A磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAA102 | BcMag™ 蛋白A磁珠 5ml | 5ml | 5850 |
| MAA103 | BcMag™ 蛋白A磁珠 10ml | 10ml | 9750 |
| MAG101 | BcMag™ 蛋白 G磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAG102 | BcMag™ 蛋白G磁珠 5ml | 5ml | 5850 |
| MAG103 | BcMag™ 蛋白G磁珠 10ml | 10ml | 9750 |
| MAL101 | BcMag™ 蛋白 L磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAL102 | BcMag™ 蛋白L磁珠 5ml | 5ml | 5850 |
| MAL103 | BcMag™ 蛋白L磁珠 10ml | 10ml | 9750 |
| EA101 | BcMag™ 快速抗体纯化试剂盒 2ml | 2ml | 2250 |
| EA102 | BcMag™ 快速抗体纯化试剂盒 10ml | 10ml | 8250 |
| EB101 | BcMag™ 一步法抗体纯化试剂盒 2ml | 2ml | 2250 |
| EB102 | BcMag™ 一步法抗体纯化试剂盒 10ml | 10ml | 8250 |
| EC101 | BcMag™ 硼酸亲和磁珠磁珠 250mg | 250mg | 5175 |
| EC102 | BcMag™ 硼酸亲和磁珠磁珠 500mg | 500mg | 9750 |
| MMI101 | BcMag™ 单体亲和素磁珠 Kit | Kit | 7275 |
| MMI102 | BcMag™ 单体亲和素磁珠 5ml | 5ml | 8250 |
| MMI103 | BcMag™ 单体亲和素磁珠 10ml | 10ml | 14250 |
| MMI105 | BcMag™ 链酶亲和素磁珠 5ml | 5ml | 5250 |
| MMI106 | BcMag™ 链酶亲和素磁珠 10ml | 10ml | 9750 |
| MMI107 | BcMag™ 可洗脱式链酶亲和素磁珠 2ml | 2ml | 3750 |
| MMI108 | BcMag™ 可洗脱式链酶亲和素磁珠 5ml | 5ml | 8250 |
| MMI109 | BcMag™ 可洗脱式链酶亲和素磁珠 10ml | 10ml | 13500 |
| FM101 | 1µm BcMag™ DEAE 磁珠 250mg | 250mg | 5175 |
| FM102 | 1µm BcMag™ DEAE 磁珠 500mg | 500mg | 9750 |
| FM103 | 5µm BcMag™ DEAE 磁珠 250mg | 250mg | 5175 |
| FM104 | 5µm BcMag™ DEAE 磁珠 500mg | 500mg | 9750 |
| FM105 | 1µm BcMag™ PSA 磁珠 250mg | 250mg | 5175 |
| FM106 | 1µm BcMag™ PSA 磁珠 500mg | 500mg | 9750 |
| FM107 | 5µm BcMag™ PSA 磁珠 250mg | 250mg | 5175 |
| FM108 | 5µm BcMag™ PSA磁珠 500mg | 500mg | 9750 |
| FN101 | 1µm BcMag™ WCX 磁珠 250mg | 250mg | 5175 |
| FN102 | 1µm BcMag™ WCX 磁珠 500mg | 500mg | 9750 |
| FN103 | 5µm BcMag™ WCX 磁珠 250mg | 250mg | 5175 |
| FN104 | 5µm BcMag™ WCX 磁珠 500mg | 500mg | 9750 |
| FU101 | 1µm BcMag™ SAX 磁珠 250mg | 250mg | 5175 |
| FU102 | 1µm BcMag™ SAX 磁珠 500mg | 500mg | 9750 |
| FU103 | 5µm BcMag™ SAX 磁珠 250mg | 250mg | 5175 |
| FU104 | 5µm BcMag™ SAX 磁珠 500mg | 500mg | 9750 |
| FV101 | 1µm BcMag™ SCX 磁珠 250mg | 250mg | 5175 |
| FV102 | 1µm BcMag™ SCX 磁珠 500mg | 500mg | 9750 |
| FV103 | 5µm BcMag™ SCX 磁珠 250mg | 250mg | 5175 |
| FV104 | 5µm BcMag™ SCX 磁珠 500mg | 500mg | 9750 |
| DA101 | 1µm BcMag™ PEI 磁珠 250mg | 250mg | 5175 |
| DA102 | 1µm BcMag™ PEI 磁珠 500mg | 500mg | 9750 |
| DA103 | 5µm BcMag™ PEI磁珠 250mg | 250mg | 5175 |
| DA104 | 5µm BcMag™ PEI 磁珠 500mg | 500mg | 9750 |
| FO101 | 1µm BcMag™ 羟基磷灰石磁珠 250mg | 250mg | 5175 |
| FO102 | 1µm BcMag™ 羟基磷灰石磁珠 500mg | 500mg | 9750 |
| FK101 | 1µm BcMag™ C-8 磁珠 250mg | 250mg | 5175 |
| FK102 | 1µm BcMag™ C-8 磁珠 500mg | 500mg | 9750 |
| FK103 | 5µm BcMag™ C-8 磁珠 250mg | 250mg | 5175 |
| FK104 | 5µm BcMag™ C-8 磁珠 500mg | 500mg | 9750 |
| FL101 | 1µm BcMag™ C-18 磁珠 250mg | 250mg | 5175 |
| FL102 | 1µm BcMag™ C-18 磁珠 500mg | 500mg | 9750 |
| FL103 | 5µm BcMag™ C-18 磁珠 250mg | 250mg | 5175 |
| FL104 | 5µm BcMag™ C-18 磁珠 500mg | 500mg | 9750 |
| FS101 | 1µm BcMag™ C-4 磁珠 250mg | 250mg | 5175 |
| FS102 | 1µm BcMag™ C-4 磁珠 500mg | 500mg | 9750 |
| FS103 | 5µm BcMag™ C-4 磁珠 250mg | 250mg | 5175 |
| FS104 | 5µm BcMag™ C-4 磁珠 500mg | 500mg | 9750 |
| FS105 | 1µm BcMag™ 氰基丙基磁珠 250mg | 250mg | 5175 |
| FS106 | 1µm BcMag™ 氰基丙基磁珠 500mg | 500mg | 9750 |
| FS107 | 5µm BcMag™ 氰基丙基磁珠 250mg | 250mg | 5175 |
| FS108 | 5µm BcMag™ 氰基丙基磁珠 500mg | 500mg | 9750 |
| FT101 | 1µm BcMag™ 苯环基磁珠 250mg | 250mg | 5175 |
| FT102 | 1µm BcMag™ 苯环基磁珠 500mg | 500mg | 9750 |
| FT103 | 5µm BcMag™ 苯环基磁珠 250mg | 250mg | 5175 |
| FT104 | 5µm BcMag™ 苯环基磁珠 500mg | 500mg | 9750 |
| FT105 | 1µm BcMag™ 二苯基磁珠 250mg | 250mg | 5175 |
| FT106 | 1µm BcMag™ 二苯基磁珠 500mg | 500mg | 9750 |
| FT107 | 5µm BcMag™ 二苯基磁珠 250mg | 250mg | 5175 |
| FT108 | 5µm BcMag™ 二苯基磁珠 500mg | 500mg | 9750 |
| AY101 | BcMag™ 高纯度质粒提取试剂盒 5ml | 5ml | 4125 |
| AY102 | BcMag™ 高纯度质粒提取试剂盒 10ml | 10ml | 7875 |
| CA101 | BcMag™ 快速 Oligo-DNA偶联试剂盒 100mg Beads Kit | 100mg Beads Kit | 5400 |
| CA102 | BcMag™ 快速 Oligo-DNA偶联试剂盒 200mg Beads Kit | 200mg Beads Kit | 9750 |
| CA103 | BcMag™ RNA-DNA偶联试剂盒 100mg Beads Kit | 100mg Beads Kit | 5400 |
| CA104 | BcMag™ RNA-DNA偶联试剂盒 200mg Beads Kit | 200mg Beads Kit | 9750 |
| MMS101 | BcMag™ 快速mRNA提取纯化试剂盒 Kit | Kit | 4800 |
| MMS102 | BcMag™ Oligo-dT 磁珠 4ml | 4ml | 5700 |
| BA101 | BcMag™ 一步法脂质清除试剂盒 1ml | 1ml | 2250 |
| BA102 | BcMag™ 一步法脂质清除试剂盒 5ml | 5ml | 10350 |
| BB101 | BcMag™ 一步法脱蛋白清除试剂盒 1ml | 1ml | 2250 |
| BB102 | BcMag™ 一步法脱蛋白清除试剂盒 5ml | 5ml | 10350 |
| BC101 | BcMag™ 一步法SDS清除试剂盒 1ml | 1ml | 2250 |
| BC102 | BcMag™ 一步法SDS清除试剂盒 5ml | 5ml | 10350 |
| BD101 | BcMag™ 一步法去垢剂清除试剂盒 1ml | 1ml | 2250 |
| BD102 | BcMag™ 一步法去垢剂清除试剂盒 5ml | 5ml | 10350 |
| BE101 | BcMag™ 快速白蛋白清除试剂盒 25x preps Kit | 25x preps Kit | 3750 |
| BE102 | BcMag™ 快速白蛋白清除试剂盒 2.5ml beads, 100x preps | 2.5ml beads, 100x preps | 9750 |
| BF101 | BcMag™ 快速 HSA-IgG清除试剂盒 25x preps Kit | 25x preps Kit | 3750 |
| BF102 | BcMag™ 快速 HSA-IgG清除试剂盒 2.5ml beads, 100x preps | 2.5ml beads, 100x preps | 9750 |
| BG101 | BcMag™ 一步法染料清除试剂盒 1ml | 1ml | 2250 |
| BG102 | BcMag™ 一步法染料清除试剂盒 5ml | 5ml | 10350 |
| BH101 | BcMag™ 固定化TCEP二硫化物还原试剂盒 100mg | 100mg | 3750 |
| BH102 | BcMag™ 固定化TCEP二硫化物还原试剂盒 500mg | 500mg | 6750 |
| MKE101 | BcMag™ 快速内毒素清除试剂盒 Kit | Kit | 5250 |
| MKE102 | BcMag™ 快速内毒素清除试剂盒 5ml Beads | 5ml Beads | 7425 |
| MKE103 | BcMag™ 快速内毒素清除试剂盒 20ml of 10x regeneration buffers | 20ml of 10x regeneration buffers | 2535 |
| FQ101 | BcMag™ EDTA金属离子清除试剂盒 150mg | 150mg | 4125 |
| FQ102 | BcMag™ EDTA金属离子清除试剂盒 300mg | 300mg | 7875 |
| BI101 | BcMag™ EGTA金属离子清除试剂盒 150mg | 150mg | 4125 |
| BI102 | BcMag™ EGTA金属离子清除试剂盒 300mg | 300mg | 7875 |

Boston Biochem隶属于R&D System公司,是全世界最大的泛素相关产品的供应商。Boston Biochem生产的泛素产品包括蛋白、多肽、底物、小分子抑制剂、酶、蛋白酶体试剂盒交联试剂等。
Boston Biochem的主要产品包括:
Affinity Matrices / Proteins
Antibodies
Autophagy
Buffers
Deconjugating Enzymes
Deubiquitinating (DUBs)
E1 Activating
E2 Conjugating
E3 Ligase
Fractions
Heat Shock Proteins
Inhibitors
Kits
NEDD8
Other Ubiquitin-like
Proteasome
Substrate Proteins
SUMO & SUMOlyation
Ubiquitin
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Boston Biochem"> Boston Biochem
美国Plant Cell Technology公司为商业及研究用植物组织培养实验室和植物种植者开发、生产了旗舰产品PPM™ (Plant Preservative Mixture),它是一种广谱抗微生物剂,可以杀死细菌和真菌细胞,防止真菌孢子的萌发,并在较高浓度下能消除内源性污染的外植体。研究表明PPM™活性成分可以渗透过真菌或细菌细胞壁,抑制柠檬酸循环和电子传递链等中心代谢循环中的关键酶的活性,并且可以抑制培养基中的单糖和氨基酸向真菌和细菌细胞的运输。PPM™能有效地抑制植物细胞和植物组织培养中的通过空气、水、人传播的微生物污染及内源性污染,而不会影响体外种子发芽、愈伤组织增殖和愈伤组织的再生。并且,PPM™具有热稳定性,可以和培养基一起灭菌,同时比常用抗生素价更低廉,可以作为植物组织培养基的标准成分。
The principal PCT scientist involved in the development of the PPM™ application is Dr. Assaf Guri. Dr. Assaf Guri holds degrees in genetics, applied genetics and plant breeding from the Hebrew University in Jerusalem and Michigan State University in the US. Before joining Plant Cell Technology, Inc., Dr. Guri worked with the Volcani Agricultural Research Center in Israel, Michigan State University in East Lansing, Michigan and DNAP in New Jersey.
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.







Berry & Associates的主要产品包括:
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸
<艾美捷科技代理Synthelis Biotech品牌全系列产品
Synthelis Biotech是一家法国公司,专注于蛋白质的生产、纯化与表征,公司致力于助力疫苗、生物制剂、酶、工程蛋白、诊断工具以及高通量分子或配体筛选技术的开发。Synthelis Biotech提供经过验证的蛋白质,其活性和纯度均根据特定应用(候选药物筛选、抗体与疫苗开发、结构生物学、体外诊断、蛋白质载体化)量身定制。Synthelis Biotech专利的无细胞技术使客户能够从不同蛋白家族(GPCRs、离子通道、转运蛋白等)和不同形式(蛋白脂质体、纳米盘、去垢剂溶解形式或可溶形式)中选择合适的蛋白质。凭借其专利技术,Synthelis 能够在数小时内合成各类蛋白质:包括膜蛋白、毒性蛋白、修饰蛋白等,应用于药物筛选、疫苗与抗体开发、结构生物学以及体外诊断等领域。同时可按需进行修饰(荧光或同位素标记、非天然氨基酸掺入、截短或突变形式等)。

▍Synthelis Biotech产品列表
| 分类 | 品名 | Protein | Origin | Format | Reference | Quantity | 分子量 |
| Viral Proteins | E1 | Envelop protein 1 | Hepatitis C virus | Proteoliposome | PL011 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 21 kDa |
| Viral Proteins | E2 | Envelop protein 1 | Hepatitis C virus | Proteoliposome | PL010 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 21 kDa |
| Viral Proteins | N-protein | Nucleocapsid Protein (COVID-19) | SARS-Cov 2 virus | Soluble | S-144 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 47,7 kDa |
| Viral Proteins | F5L | Vaccinia virus major membrane protein | Vaccinia virus | Proteoliposome | PL007 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 39.0 kDa |
| Viral Proteins | HCV p7 | Hepatitis C virus P7 | HCV virus | Proteoliposome | PL042 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 7 kDa |
| GPCRs | APJ/AR | Apelin Receptor | Human | Proteoliposome | PL061 | 10 µg, 50 µg ,100 µg | 44.7 kDa |
| GPCRs | B2R | Bradykinin receptor 2 | Human | Proteoliposome | PL080 | 10 µg, 50 µg ,100 µg | 47.0 kDa |
| GPCRs | BR | Bacteriorhodopsin | Bacteria | Proteoliposome | PL027 | 10 µg, 50 µg ,100 µg | 29.4 kDa |
| GPCRs | CCR1 | C-C chemokine receptor type 1 | Human | Proteoliposome | PL021 | 10 µg, 50 µg ,100 µg | 43.7 kDa |
| GPCRs | CCR2a | C-C chemokine receptor type 2, isoform a | Human | Proteoliposome | PL022 | 10 µg, 50 µg, 100 µg | 44.5 kDa |
| GPCRs | CCR2b | C-C chemokine receptor type 2, isoform b | Human | Proteoliposome | PL023 | 10µg, 20µg,100 µg, 200 µg | 42 kDa |
| GPCRs | CCR5 | C-C chemokine receptor type 5 | Human | Proteoliposome | PL024 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 40 kDa |
| GPCRs | CXCR4 | C-X-C chemokine receptor type 4 | Human | Proteoliposome | PL016 | 10 µg, 50 µg, 100 µg | 43 kDa |
| GPCRs | CXCR4-Detergent | C-X-C chemokine receptor type 4 | Human | Detergent | D016 | 25µg ,100 µg ,500 µg,bulk | 40 kDa |
| GPCRs | GLP1R | Glucagon-like peptide 1 receptor | Human | Proteoliposome | PL067 | 10 µg, 50 µg, 100 µg | 55.5 kDa |
| GPCRs | GPR50 | G-protein coupled receptor 50 | Human | Proteoliposome | PL095 | 10 µg, 50 µg, 100 µg | 67.4 kDa |
| GPCRs | GPR54 | G-protein coupled receptor 54 | Human | Proteoliposome | PL097 | 10 µg, 50 µg ,100 µg | 45.2 kDa |
| GPCRs | HMOP | Mu-type opioid receptor | Human | Proteoliposome | PL025 | - | - |
| GPCRs | MT1 | Melatonin receptor | Human | Proteoliposome | PL028 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 40 kDa |
| GPCRs | RXFP1 | Relaxin receptor 1 | Human | Proteoliposome | PL068 | 10 µg, 50 µg ,100 µg | 89.1 kDa |
| Ion Channels | kir1.1b | ATP-sensitive inward rectifier potassium channel 1 isoform b | Mouse | Proteoliposome | PL031 | 10µg, 20µg,100 µg, 200 µg, 500 µg, bulk | 42.7 kDa |
| Ion Channels | kv1.2 | Potassium voltage-gated channel subfamily A, member 2 | Rat | Proteoliposome | PL037 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 57 kDa |
| Ion Channels | kv1.3 | Potassium voltage-gated channel subfamily A, member 3 | Mouse | Proteoliposome | PL036 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 58 kDa |
| Ion Channels | VDAC1 | Voltage-Dependent Anion Channel 1 | Human | Proteoliposome | PL029 | 10 µg, 50 µg ,100 µg | 30.7kDa |
| Ion Channels | VDAC1 – Detergent | Voltage-Dependent Anion Channel 1 | Human | Detergent | D029 | 10 µg, 50 µg, 100 µg | 30.7kDa |
| Ligands | SDF1a | Stromal cell-derived factor 1 | Human | Soluble | S069 | 10 µg, 50 µg ,100 µg | 10.7 kDa |
| Porins | OEP24 | Outer envelope pore protein 24, chloroplastic | Plant | Proteoliposome | PL040 | 10 µg, 50 µg ,100 µg | 24 kDa |
| Porins | OprF | Outer membrane porin F | Bacteria | Proteoliposome | PL045 | 10 µg, 50 µg, 100 µg | 40 kDa |
| Enzymes | gp91phox (Nox2 subunit) | gp91phox | Human | Proteoliposome | PL008 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 55 kDa |
| Enzymes | KMO | Kynurenine 3-monooxygenase | Human | Proteoliposome | PL005 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 55,8 kDa |
| Enzymes | Nox2, p22 Phox | Cytochrome b-245 light chain | Human | Proteoliposome | PL039 | 10 µg, 50 µg ,100 µg | 23,5 kDa |
| Enzymes | Nox4 | Nox4 | Human | Proteoliposome | PL059 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 67 kDa |
| Enzymes | PORCN | Protein-Cysteine N-palmitoyltransferase porcupine | Human | Proteoliposome | PL006 | 10 µg, 50 µg, 100 µg | 55.5 kDa |
| Enzymes | TF | Tissue factor | Human | Proteoliposome | PL053 | 10µg, 20µg ,50µg, 100 µg , 200µg, 500 µg,bulk | 33 kDa |
| Enzymes | T7 RNA Pol | T7 RNA Polymerase | Bacteriophage T7 | Soluble | S192 | 10 µg, 50 µg, 100µg | 100.1 kDa |
| Enzymes | DsbC | Disulfide bond isomerase | E.coli | Soluble | S197 | customized quantity on request. | 25.4 kDa |
| Receptors | CLDN 18.2 | Claudin 18.2 Protein | Human | Proteoliposome | PL119 | 10 µg, 50 µg, 100 µg | 30 kDa |
| Transcriptional regulators | AROS | Active regulator of SIRT1 | Human | Proteoliposome | S052 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 15,4 kDa |
| Transporters | Bak | Bcl-2 homologous antagonist killer | Human | Proteoliposome | PL038 | 25µg ,100 µg ,500 µg,bulk | 17 kDa |
| Transporters | EspH | Cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli | Bacteria | Proteoliposome | PL051 | 10 µg, 50 µg, 100 µg | 21.9 kDa |
| Transporters | HCV p7 | Hepatitis C virus P7 | Virus | Proteoliposome | PL042 | 25µg ,100 µg ,500 µg,bulk | 7 kDa |
| Transporters | NhaA | Na(+)/H(+) antiporter NhaA | E. coli | Proteoliposome | PL032 | 10 µg, 50 µg, 100 µg | 43.9 kDa |
| Transporters | UCP1 | Mitochondrial brown fat uncoupling protein 1 | Mitochondria | Proteoliposome | PL047 | 10 µg, 50 µg, 100 µg | 35.1 kDa |

TiterMax®佐剂被用于增强免疫反应。TiterMax®佐剂有着跟弗氏佐剂相同的功效,但具有更安全、更易用的特点,是弗氏佐剂的理想代替产品。
TiterMax® adjuvants are used to produce cell mediated and humoral responses in research animals. TiterMax® adjuvants were developed to meet the specific needs of investigators for immunoadjuvants that are at least as effective as Freund's Complete Adjuvant, safer and easier to use. They are an attractive alternative to Freund's Complete Adjuvant for use by researchers in inducing antibody to diverse antigens. The key to the potency of TiterMax® adjuvants lies both in the immunostimulatory activity of their components and in the fact that they form a stable water-in-oil emulsion. TiterMax® adjuvants contain three essential ingredients: Proprietary block copolymers, squalene, a metabolizable oil, and a unique microparticulate stabilizer. Like Freund's Complete Adjuvant, TiterMax® adjuvants can be used with a wide variety of antigens because they can entrap any antigen in a water-in-oil emulsion. TiterMax® adjuvants aid in the antigens effective presentation to the immune system without the toxic effects of Freund's Complete Adjuvant.
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="TiterMax"> TiterMax地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18995651644
传真:18771997407
邮箱:sales@amyjet.com
0.2734